Gilead Sciences to Present at Two Upcoming Investor Conferences
November 25 2008 - 4:15PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the
company will be webcasting its corporate presentation at two
upcoming investor conferences: the 20th Annual Piper Jaffray Health
Care Conference in New York and the NASDAQ OMX 22nd Investor
Program in London. These webcasts may be accessed via the company�s
corporate website at www.gilead.com. John F. Milligan, PhD,
Gilead�s President and Chief Operating Officer, will provide an
overview of the company at the Piper Jaffray conference on Tuesday,
December 2 at 9:30 a.m. Eastern Standard Time (EST). Kevin Young,
Gilead�s Executive Vice President of Commercial Operations, will
provide an overview of the company at the NASDAQ OMX Investor
Program on Thursday, December 4 at 3:15 p.m. Greenwich Mean Time
(10:15 a.m. EST). To access the live webcasts via the internet log
on to www.gilead.com. Please connect to the company�s website at
least 15 minutes prior to each live presentation to ensure adequate
time for any software download that may be necessary to listen to
the webcast. About Gilead Gilead Sciences is a biopharmaceutical
company that discovers, develops and commercializes innovative
therapeutics in areas of unmet medical need. The company's mission
is to advance the care of patients suffering from life-threatening
diseases worldwide. Headquartered in Foster City, California,
Gilead has operations in North America, Europe and Australia. For
more information on Gilead Sciences, please visit www.gilead.com or
call the Gilead Public Affairs Department at 1-800-GILEAD-5
(1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jul 2023 to Jul 2024